Filter
180
Filtered Results: 180
Text search:
Patton
G.
et
al.
Featured
Recommendations
13
New Publications
27
Language
Document type
No document type
88
Studies & Reports
47
Guidelines
24
Manuals
11
Resource Platforms
3
Training Material
2
Strategic & Response Plan
2
Fact sheets
2
Situation Updates
1
Countries / Regions
Global
9
Africa
5
Ukraine
4
Western and Central Europe
4
Brazil
4
India
4
Thailand
3
Kenya
3
Burkina Faso
3
Uganda
3
Eastern Europe
3
Russia
3
Colombia
2
Senegal
2
Asia
2
Tanzania
2
Germany
2
Paraguay
2
Bangladesh
2
South Africa
2
Zambia
2
Lesotho
1
Sierra Leone
1
Rwanda
1
Chile
1
Cameroon
1
Singapore
1
Malawi
1
Philippines
1
Guinea
1
Mozambique
1
Cambodia
1
Latin America and the Carribbean
1
Congo, Democratic Republic of
1
South–East Asia Region
1
Western Pacific Region
1
Portugal
1
East and Southern Africa
1
Palestine
1
Ethiopia
1
Angola
1
Chad
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
39
Clinical Guidelines
16
Public Health
10
Women & Child Health
7
Key Resources
4
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
Mental Health
37
HIV
37
Planetary Health
12
Ebola & Marburg
9
AMR
8
NTDs
6
COVID-19
5
Caregiver
5
NCDs
5
Rapid Response
4
TB
3
Health Financing Toolbox
3
Global Health Education
3
Refugee
2
Disability
2
Specific Hazards
1
Pharmacy
1
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Discussion Paper "Mental health, poverty and development", July 2009
Dignity in Mental Health
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
The Lancet Published Online
October 8, 2021 https://doi.org/10.1016/ S0140-6736(21)02143-7
Módulo 1
Clínico
Julho de 2017
Módulo 1: Clínico. Este módulo é destinado a profissionais de saúde como médicos, enfermeiros e auxiliares e traz um resumo sobre como prover a PrEP de forma segura e efetiva, abordando vários aspectos: triagem de pessoas com risco substancial de contr...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
Effective risk communication requires the alignment of complex factors including trust between the communicator and the audience(s), audience involvement, and emotional responses to risk. Risk communication is especially challenging now as new media changes the landscape for both
communicators and...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Accessed: 27.11.2019
WHO Western Pacific Regional Strategy to Reduce Alcohol-Related Harm
A review of prospects for existing antibiotics ad new therapeutics
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
Technical report
February 2015
